日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A pragmatic, single-arm clinical trial of a dose modification algorithm for preventing cytopenia-related delays during FOLFOX chemotherapy

一项务实的单臂临床试验，旨在研究一种剂量调整算法在预防FOLFOX化疗期间因细胞减少症引起的治疗延误方面的应用。

期刊:Supportive Care in Cancer
影响因子:3
doi:10.1007/s00520-025-09784-0
Wright, Heather N; Tosteson, Tor D; Hourdequin, Kathryn C; Ripple, Gregory H; Fuld, Alexander D; Dragnev, Konstantin H; Amin, Manik; Muralikrishnan, Sivraj; McGrath, Elizabeth B; Stannard, Maureen G; Schofield, Lora L; Lord-Halvorson, Sierra; Tosteson, Anna N A; Brooks, Gabriel A
细胞生物学
发表日期：2025
文献求助 收藏

Association of DPYD rs4294451, plasma uracil concentration, and sex with 5-fluorouracil exposure in patients with gastrointestinal cancer

DPYD rs4294451、血浆尿嘧啶浓度和性别与胃肠道癌症患者5-氟尿嘧啶暴露的相关性

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-025-04851-z
Brooks, Gabriel A; Ness, Dylan B; Hourdequin, Kathryn C; Ripple, Gregory H; Amin, Manik; Lord-Halvorson, Sierra; Khan, Wahab A; Deharvengt, Sophie J; Busque, Vincent; Dragnev, Konstantin H; Zhao, Wenyan; Tosteson, Tor D; Lewis, Lionel D
DPYD
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Surveillance With Serial Imaging and CA 19-9 Tumor Marker Testing After Resection of Pancreatic Cancer: A Single-Center Retrospective Study

胰腺癌切除术后采用连续影像学检查和CA 19-9肿瘤标志物检测进行监测：一项单中心回顾性研究

期刊:American Journal of Clinical Oncology-Cancer Clinical Trials
影响因子:1.8
doi:10.1097/COC.0000000000001052
Nong, Minerva Z; Dove, Devanshi; Fischer, Dawn A; Hourdequin, Kathryn C; Ripple, Gregory H; Amin, Manik A; McGrath, Elizabeth B; Zaki, Bassem I; Smith, Kerrington D; Brooks, Gabriel A
胰腺癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏